September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.
GE Healthcare Medical Diagnostics’ VISIPAQUE is reportedly the only isosmolar contrast medium (IOCM) available in the U.S. With an osmolality equal to that of blood, VISIPAQUE was designed for patient safety and comfort and is also formulated with sodium and calcium in a ratio equivalent to blood.
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 5, 2007 - The National Institutes of Health has awarded its $5 million Bioengineering Research Partnership ...
September 5, 2007 - Edwards Lifesciences Corp. announced that it has received CE Mark approval for European commercial ...
September 5, 2007 - Results from a study on acute cardiogenic pulmonary edema, or "fluid on the lung," presented at the ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
September 4, 2007 - The first few minutes are instrumental in emergency situations and a new portable ultrasound device ...
September 4, 2007 - Agfa HealthCare demonstrated at the European Society of Cardiology Congress 2007 its new IMPAX ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 4, 2007 – Philips recently demonstrated its HeartStart MRx monitor/defibrillator that enables paramedics to ...
September 4, 2007 - Siemens Medical Solutions expanded its portfolio of ultrasound applications with the syngo Arterial ...
September 4, 2007- New recommendations released today in the Journal of the American Society of Echocardiography further support the role of stress echo in accurately identifying coronary artery disease (CAD), determining prognosis of patients with known or suspected CAD, in addition to providing recommendations for optimizing imaging.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
September 4, 2007 – At the European Society of Cardiology’s (ESC) annual congress, Royal Philips Electronics ...
August 31, 2007 - Baby boomers need to understand how to maintain a healthy vascular system as they become seniors. By ...
September 05, 2007
